VIP (Vasoactive Intestinal Peptide) 10mg

 99,00

VIP (Vasoactive Intestinal Peptide) 10 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms greater than 99.8 percent purity, endotoxins below 0.001 EU per mg and no detectable heavy metals or microbial contamination.
Supplied as a 10 mg lyophilized neuroregulatory research peptide with full COA traceability.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.
For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview VIP (Vasoactive Intestinal Peptide) is a neuroregulatory research peptide investigated for its role in cellular signalling, neuroimmune communication and receptor-mediated biochemical pathway modelling. This 10 mg lyophilized preparation supports controlled in-vitro research into peptide-driven signalling dynamics within regulated laboratory environments.   Peptide Overview VIP was first identified in 1970 during foundational investigations into gut-derived neuropeptides and vasoactive signalling molecules. Throughout the 1970s and 1980s, scientific interest expanded as laboratories explored its involvement in neuroimmune signalling, vascular regulation and receptor-associated communication systems. From 1990 to 2025 VIP has remained a widely used reference peptide in advanced research models examining neuroregulation, immune-related signalling pathways and intracellular communication under controlled experimental conditions.   Historical Background and Scientific Context Between 1970 and 1990 early research established VIP as a key signalling peptide within the broader family of neuropeptides involved in autonomic, vascular and immune-modulated communication. Its clearly defined structure and reproducible analytical behaviour contributed to its adoption in mechanistic laboratory research. From 2000 onward, VIP continued to be incorporated into pathway-modelling studies focused on receptor binding, signalling-cascade behaviour and structure–function relationships across neuroimmune and regulatory biochemical systems.   Structural & Molecular Characteristics • Amino-acid chain length: 28 amino acids • Peptide family: neuroregulatory signalling peptide • Structural classification: linear peptide • Typical molecular weight: approximately 3326 Da • Functional domain: neuroimmune and vasoactive signalling region   Mechanistic Focus in Research
  • Neuroregulatory and neuroimmune signalling pathway modelling
  • Receptor-associated peptide interaction analysis
  • Structure–function evaluation of vasoactive peptides
  • Intracellular communication and signalling-cascade studies
  • Controlled in-vitro biochemical modelling
  Analytical Verification (COA) Independent laboratory analysis performed by Liquilabs s.r.o. (Czechia) confirms full analytical validation for this batch. Testing confirms greater than 99.8 percent purity, verified identity through chromatographic retention time and spectral analysis, and assay content within specification. Endotoxin levels were confirmed below 0.001 EU per mg, with no detectable microbial growth or heavy metals. All analytical values were obtained using validated laboratory methodologies with full batch traceability.  

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use
  • Independently analysed by Liquilabs s.r.o. Czechia
  • Greater than 99.8 percent purity
  • Endotoxins below 0.001 EU per mg
  • No detectable heavy metals or microbial contamination
  • Neuroregulatory and neuroimmune signalling research peptide
  • EU shipments include bacteriostatic water
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products